Pacer Advisors Inc. reduced its position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 16.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 761,477 shares of the company’s stock after selling 149,619 shares during the quarter. Pacer Advisors Inc. owned 0.34% of HCA Healthcare worth $355,503,000 as of its most recent SEC filing.
Several other institutional investors have also recently modified their holdings of HCA. Palisade Asset Management LLC acquired a new position in HCA Healthcare in the 3rd quarter worth approximately $26,000. Holos Integrated Wealth LLC purchased a new position in shares of HCA Healthcare during the fourth quarter worth $29,000. Ares Financial Consulting LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at $31,000. JPL Wealth Management LLC acquired a new position in HCA Healthcare in the third quarter valued at $33,000. Finally, Aventura Private Wealth LLC purchased a new position in HCA Healthcare during the 4th quarter worth approximately $34,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
HCA Healthcare Stock Performance
Shares of HCA opened at $375.37 on Friday. The business’s fifty day moving average price is $422.27 and its two-hundred day moving average price is $469.71. The firm has a market capitalization of $83.27 billion, a price-to-earnings ratio of 12.91, a PEG ratio of 1.23 and a beta of 1.12. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52.
HCA Healthcare Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is 10.73%.
Analyst Ratings Changes
HCA has been the subject of a number of analyst reports. Leerink Partners cut their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Deutsche Bank Aktiengesellschaft cut their price objective on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research report on Tuesday, April 28th. Robert W. Baird decreased their price objective on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Stephens decreased their price objective on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Finally, Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Fifteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $506.14.
Get Our Latest Stock Analysis on HCA Healthcare
About HCA Healthcare
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Further Reading
- Five stocks we like better than HCA Healthcare
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
